Aanika Biosciences is a technology company.
Aanika Biosciences is a technology company.
Aanika Biosciences has raised $14.0M across 2 funding rounds.
Aanika Biosciences has raised $14.0M in total across 2 funding rounds.
Aanika Biosciences has raised $14.0M in total across 2 funding rounds.
Aanika Biosciences's investors include Cygnus Capital, Draper Associates, SOSV, Curious Capital, Norrsken VC, Operator Partners, Marco DeMeireles, Curtis Lee.
Aanika Biosciences is a biotechnology company founded in 2018 and headquartered in Brooklyn, New York, that develops microbial-based tags using synthetic biology to enhance food supply chain integrity, prevent contamination, and reduce losses for large food and agricultural companies.[1][2][3] It serves agribusinesses and food producers by addressing issues like spray drift, product contamination, and warranty programs, with solutions including property-damage coverage for herbicide drift currently under development; the company has raised $12 million in funding, including a recent seed round supporting Aanika Re, a Bermuda-based reinsurance vehicle approved by the Bermuda Monetary Authority to apply its tracking technology to insurance risks in agriculture.[2][4]
Aanika Biosciences was established in 2018 in Brooklyn, New York, focusing from the outset on synthetic biology innovations for food security.[2][3][5] Key early developments include creating microbial tags to track and trace products in supply chains, leading to pivotal milestones like securing $12 million in total funding and Bermuda Monetary Authority Sandbox approval for Aanika Re—a wholly-owned reinsurance entity leveraging this technology to mitigate agricultural risks such as prevention, identification, and insurance against losses.[1][2] Specific founder details are not publicly detailed in available sources, but the company's evolution from core tagging tech to reinsurance applications marks its growth trajectory.[2]
Aanika rides the wave of synthetic biology intersecting with agriculture and insurtech, capitalizing on rising demands for supply chain transparency amid global food security challenges like contamination outbreaks and climate-driven risks.[1][2] Timing aligns with post-2020 emphases on resilient agrotech, where microbial innovations enable non-chemical, precise tracking superior to RFID or chemical markers; market forces like escalating agricultural losses (trillions in potential insurance exposure) favor its reinsurance pivot.[2][4] By pioneering biotech in reinsurance via Bermuda's sandbox, Aanika influences the ecosystem, bridging startups with incumbents in a sector blending biology, data, and finance for broader adoption of bio-engineered risk tools.[2]
Aanika's reinsurance expansion via Aanika Re positions it to disrupt ag-insurance with scalable microbial tech, potentially capturing share in high-stakes markets as climate volatility amplifies drift and contamination claims.[2][4] Trends like AI-enhanced bio-tracking and regulatory sandboxes will accelerate growth, evolving its role from food security provider to ecosystem shaper in synth-bio agrotech. Watch for partnerships scaling warranty programs and global pilots, amplifying its supply chain integrity mission amid trillion-dollar opportunities.[1][2]
Aanika Biosciences has raised $14.0M across 2 funding rounds. Most recently, it raised $12.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2021 | $12.0M Series A | Cygnus Capital, Draper Associates, SOSV | |
| Nov 1, 2019 | $2.0M Seed | Curious Capital, Norrsken VC, Operator Partners, SOSV, Marco DeMeireles, Curtis Lee |